Eli Lilly and Eagle Pharma settle antitrust and infringement claims

18-12-2019

Saman Javed

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

Jonathan Weiss / Shutterstock.com

US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.


Eagle Pharmaceuticals, Eli Lilly, cancer, Pemfexy, Alimta, generics, patent infringement, antitrust, US Court of Appeals for the Federal Circuit

LSIPR